AffaMed Therapeutics
Alan Lu started their work experience as a Chief Accountant at Shenzhen Tianyin Communication Development Co., Ltd in July 2003. Alan held this position until December 2006.
Alan then joined Sandoz as a Business Planning and Analyzing Manager in May 2007. Alan was responsible for managing the Budgeting/Latest estimate process and aligning the company's targets with sales teams. Alan also served as a Finance operation manager, where they were in charge of finance process control, coordination with local government, and ensuring the plant achieved financial targets. Alan held these roles until October 2014.
Next, Alan Lu worked at Kangdele as a Senior FP&A Manager from October 2014 to April 2019. In this role, they acted as a finance business partner to various functions and led the China Capital review process.
Currently, they serve as the Financial Director at AffaMed Therapeutics, starting from April 2019.
From 1999 to 2003, Alan Lu attended Nanjing University of Aeronautics and Astronautics, where they obtained a Bachelor's degree in Accounting.
This person is not in any teams
AffaMed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.